CDKN2A and cancer: This study quantified and validated four cervical precancer and cancer biomarkers—TOP2A, MCM2, VCP, and p16INK4a—in lysates of cultured HeLa, Ca Ski, HT-3, and C-33 A cancer cell lines, as well as normal PCS cells, clinical cervical swab specimens, and cervical tissues.